RxDoctor Payments Data

Alexander Misono, MD

Vascular & Interventional Radiology · Newport Beach, CANPI 1992068357

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Inari Medical, Inc. at 57.4% of the total. 2025 is the largest year on record at $389,798, more than ten times the $5,605 reported in 2019. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,267,082in general payments, 2019–2025

Across 1,035 payments — averaging $1224.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$728K
  • Stryker$212K
  • Merit Medical Systems Inc$75K
  • Trisalus Life Sciences, Inc.$63K
  • Microvention, Inc.$62K
  • Argon Medical Devices, Inc.$31K
  • plus $97K from 27 others
$119,743in research payments, 2019–2025

Across 20 payments — averaging $5987.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$72K
  • Stryker$28K
  • Inari Medical, Inc.$19K

What the payments were for

  • Consulting fees$551,37944%
  • Speaking & faculty fees$495,40039%
  • Travel & lodging$181,81014%
  • Food & beverage$38,2603%
  • Education$2060%
  • Entertainment$270%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,267,082 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$139,834
Medicare patients
704
Services billed
1,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl11$735
Methylprednisolone14$94
Ciprofloxacin Hcl16$82
Ondansetron Hcl13$68

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →